Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1200 participants
OBSERVATIONAL
2015-10-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of the present study is to demonstrate that collaboration between the intensivist and other medical teams in ward can reduce ICU readmission and hospital mortality after ICU discharge.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study in Intensive Care Follow-up Programme in Improving Long-term Outcomes of ICU Survivors
NCT01796509
International Multicenter Study of In-hospital Outcome of Patients After ICU Discharge
NCT02347150
Hospital Management and 1-year Outcome of Patients Aged 70 Years and Older With Severe COVID-19
NCT05184166
Prediction of Safe Discharge From ICU
NCT05459350
French and EuRopean Outcome Registry in Intensive Care Unit
NCT01367093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Anticipate results The collaboration of attending intensivist might reduce ward mortality after ICU discharge by 3%.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
None intervention
Investigators will study the usual medical assistance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients with Sabadell Score 0 (good prognosis)
* patients with Sabadell Score 3 (null expected survival)
* patients transferred to other hospitals
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Althaia Xarxa Assistencial Universitària de Manresa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Silvia Cano Hernández
Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Silvia Cano Hernández, Physician
Role: PRINCIPAL_INVESTIGATOR
Althaia Xarxa Assistencial Universitaria de Manresa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Althaia Xarxa Assistencial Universitaria de Manresa
Manresa, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Althaia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.